The drug, geranylgeranyltransferase inhibitor GGTI-2418 suppresses a new defective PTEN cancer pathway, researchers have discovered.
Author: Latest Science News -- ScienceDaily
Wireless charging of moving electric vehicles overcomes major hurdle
Scientists have developed a way to wirelessly deliver electricity to moving objects, technology that could one…
How brain circuits govern hunger and cravings
By developing a new approach to imaging and manipulating particular groups of neurons in the mouse…
UTI treatment reduces E. coli, may offer alternative to antibiotics
Urinary tract infections (UTIs) tend to come back, even when treated. Most UTIs are caused by…
Molecular pilot light prepares body’s heating system for the cold
Researchers detail a molecule that acts as a molecular pilot light required to turn on the…
Surprising new link between inflammation and mental illness
Up to 75 percent of patients with systemic lupus erythematosus -- an incurable autoimmune disease commonly…
Hydroelectric dams may jeopardize the Amazon’s future
Hundreds of built and proposed hydroelectric dams may significantly harm life in and around the Amazon…
Bioengineered human livers mimic natural development
Researchers bioengineering human liver tissues uncovered previously unknown networks of genetic-molecular crosstalk that control the organ's…
Eyes in the sky reveal extent of gray seal recovery
Using research drones, thermal cameras and free images from Google Earth, two studies confirm that gray…
Protein network signals found to drive myeloid leukemias
Researchers have uncovered how mutations in a protein network drive several high-risk leukemias, offering new prospects…